However, TH and DAT immunoreactivity were higher in the animals receiving PLs-GDNF-MBs for 3 weeks, indicating the neuroprotective effects of PLs-GDNF-MBs in the rats with PD. The gene discussed is GDNF; the disease is Parkinson disease.